Expression of the primary female sex behaviour, lordosis, in laboratory animals depends on oestrogen-induced expression of progesterone receptor (PgR) within a defined cell group in the ventrolateral portion of the ventromedial nucleus of the hypothalamus (VMH). The minimal latency from oestradiol administration to lordosis is 18 h. During that time, ligand-bound oestrogen receptors (ER), members of a nuclear receptor superfamily, recruit transcriptional coregulators, which induce covalent modifications of histone proteins, thus leading to transcriptional activation or repression of target genes. The present study aimed to investigate the early molecular epigenetic events underlying oestrogen-regulated transcriptional activation of the Pgr gene in the VMH of female mice. Oestradiol (E 2 ) administration induced rapid and transient global histone modifications in the VMH of ovariectomised female mice. Histone H3 N-terminus phosphorylation (H3S10phK14Ac), acetylation (H3Ac) and methylation (H3K4me3) exhibited distinct temporal patterns facilitative to the induction of transcription. A transcriptional repressive (H3K9me3) modification showed a different temporal pattern. Collectively, this should create a permissive environment for the transcriptional activity necessary for lordosis, within 3-6 h after E 2 treatment. In the VMH, changes in the H3Ac and H3K4me3 levels of histone H3 were also detected at the promoter region of the Pgr gene within the same time window, although they were delayed in the preoptic area. Moreover, examination of histone modifications associated with the promoter of another ER-target gene, oxytocin receptor (Oxtr), revealed gene-and brain-region specific effects of E 2 treatment. In the VMH of female mice, E 2 treatment resulted in the recruitment of ERa to the oestrogen-response-elements-containing putative enhancer site of Pgr gene, approximately 200 kb upstream of the transcription start site, although it failed to increase ERa association with the more proximal promoter region. Finally, E 2 administration led to significant changes in the mRNA expression of several ER coregulators in a brain-region dependent manner. Taken together, these data indicate that, in the hypothalamus and preoptic area of female mice, early responses to E 2 treatment involve highly specific changes in chromatin structure, dependent on cell group, gene, histone modification studied, promoter/enhancer site and time following E 2 .
behaviour of female rodents, lordosis, is known to critically depend on the actions of oestrogens within the defined neuronal group in the hypothalamus, ventromedial nucleus of hypothalamus (VMH) (3) (4) (5) .
The mechanism by which oestrogens modulate reproductive behaviour is through the transcriptional induction of target genes and the coordinated actions of these gene products promote different aspects of lordosis (6) . Oestrogens regulate transcription through binding to their cognate receptors, oestrogen receptor (ER) a (7) and ERb (8) , which are both members of the nuclear receptor superfamily of transcription factors. Upon ligand binding, ERs dimerise and translocate to the nucleus where they bind to specific DNA sequences called oestrogen response elements (EREs) within the regulatory regions of target genes (9) (10) (11) . Studies using genetically modified mice with disrupted ERa, as well as temporally restricted knockdown of this receptor, specifically in the VMH, confirm that signalling through ERa is critical for reproduction and the expression of sexual behaviour in response to oestrogens (12) (13) (14) .
One of the most important regulatory steps in the transcriptional activity of hormone receptors is the interaction with cofactors, which link them to the basal transcriptional machinery. Furthermore, these cofactors are able to regulate transcription by modifying chromatin structure through covalent histone modifications (15) . To date, a large number of cofactors involved in ER-mediated transcription have been identified. Among them are coactivators with histone acetyltransferase (HATs) activity, members of the p160 subfamily (steroid-receptor coactivators; SRCs) (16) and the integrator complex p300/CBP (17) ; histone methyltransferases (HMTs) such as CARM1, PRMT1 and MLLs (18) (19) (20) ; and corepressors, NCOR and SMRT, which recruit histone deacetylases to target gene promoters (21, 22) . Because of the central role of coregulators in ER-mediated transcriptional regulation, they have long been regarded as the critical determining factors of specificity of oestrogen action.
Among the ER target genes, the induction of the Pgr gene by oestradiol (E 2 )-activated ERa within the VMH, is one of the earliest and most essential steps in the sequence of events that lead to the expression of female sex behaviours and successful reproduction in rodents (23) . Pgr is considered one of the classic ERa target genes and its induction by E 2 has been extensively studied in a number of E 2 -responsive tissues, most notably in mammary epithelial and breast cancer cells, as well as in the brain. However, as the data accumulate, it has become increasingly clear that the regulation of Pgr by ligand-activated ERa is quite complex and displays tissue and age-dependent patterns (24) (25) (26) . The requirement of different SRC isoforms for the regulation of Pgr gene expression by E 2 -activated ER is one clear example of a tissue-specific hormonal effect. In the human MCF-7 breast cancer cell line, the expression of the Pgr gene in response to E 2 stimulation requires SRC3, but not SRC1 and SRC2 (27, 28) . By contrast, in the brains of rats and mice, SRC1 and SRC2 are necessary for the induction of the Pgr gene, as well as the expression of reproductive behaviour, whereas SRC3 is dispensable for both (29, 30) .
The Pgr gene produces two protein isoforms, PgR-A (94 kDa) and PgR-B (120 kDa), through two alternate transcription start sites (TSS). Moreover, two functional promoters that direct the transcription of each Pgr isoforms have been characterised for human and rat Pgr genes (31) (32) (33) . Although the transcription of the Pgr gene is directly regulated by ERa, there are no consensus ERE motifs near the transcription start sites. There is, however, an ERE half site within the Pgr-A promoter, which is conserved in the mouse, rat and human genome (31) (32) (33) . Recently, several ERa binding sites have been identified between 48 and 311 kb upstream of the human PGR-B TSS (34, 35) . Three of these sites have been shown to associate with the TSS in an E 2 -dependent manner, suggesting that they may act as enhancers responsible for PGR gene transcription (35) . Despite these recent advances, little is known about the molecular mechanisms involved in the regulation of Pgr gene expression by ligand-activated ERa in the mouse nervous tissue.
For decades, the human breast cancer cell system has been the primary source of information about the effects of oestrogens and transcriptional activity of ERs. However, the important physiological role of oestrogens on nervous system functions creates a need to understand the molecular actions of these steroid hormones in nervous tissue. In the present study, we investigated the early molecular events associated with E 2 -mediated regulation of Pgr gene transcription in the mouse brain. Total levels of histone modifications in the VMH of female mice, as well as acetylation and K4 methylation of histone H3 at the promoter of the Pgr gene, were examined to determine the effects of E 2 on chromatin architecture and E 2 -target gene expression. We also performed comparative analyses of histone modifications at the promoters of two of E 2 -target genes, Pgr and Oxtr, in two E 2 -responsive hypothalamic nuclei, VMH and preoptic area (POA), aiming to investigate the molecular mechanisms of gene-and region-specific effects of E 2 in the brain. Chromatin immunoprecipitation (ChIP) was performed on the VMH tissue of female mice to detect the recruitment of ERa to the putative regulatory sequences of the Pgr gene and led to the identification of an E 2 -regulated site approximately 200 kb upstream of TSS of the mouse Pgr gene. In addition, mRNA expression analysis in the VMH and POA of female mice revealed that E 2 regulates the transcript levels of several histone-modifying factors also in a region-specific manner, providing mechanistic clues as to how the exposure to oestrogens leads to changes in the status of histone proteins.
Materials and methods

Treatment and tissue collection
Animals were handled in accordance with the National Institutes of Health and Rockefeller University Institutional Animal Care and Use Committee guidelines. Six-to 8-week-old female Swiss-Webster mice were ovariectomised (OVX). After recovery for 1 week, mice were injected i.p. with 20 lg of 17b-oestradiol (E 2 ) (Sigma, St Louis, MO, USA) diluted in 100 ll of vehicle solution (10% ethanol/saline). Control mice were injected only with vehicle (Veh) solution. Mice were sacrificed 1, 3, 6 and 9 h after E 2 injections, the brains removed and immediately frozen. VMH and POA were dissected from each brain on a dry-ice bed and kept frozen until processed. For dissections, frozen brain was placed on dry ice ventral side up and slices containing areas of interest were cut using brain mold and sterile blades. For POA, the optic chiasm and olfactory tubercle were used as landmarks to isolate an approximately 0.5-mm slice between 0.5 and 0.10 relative to bregma; and, for VMH, the pituitary stalk and mammary bodies were used as landmarks to isolate an approximately 1-mm slice between À1.22 and À2.06 relative to bregma. Subsequently, areas containing POA and VMH were dissected from coronal slices according to the mouse brain atlas (36) .
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting VMH tissue was thawed in lysis buffer containing protease, phosphatase and deacetylase inhibitors. Tissue was homogenised in 2% SDS buffer to ensure total disruption of the plasma membrane, as well as the nuclear envelope. For the SDS-PAGE and Western blot analysis, VMH tissue from two mice was pooled. The total protein concentration was determined using a BCA protein assay kit (Thermo Fisher Scientific, Rockford, IL, USA) and 30 lg of protein was ran on 4-20% gradient Tris-glycine Ready gels (Bio-Rad, Hercules, CA, USA). Protein was transferred onto polyvinylidene fluoride membrane (Bio-Rad) and blocked for 1 h at room temperature (RT) in 5% TBS-milk. Primary antibodies that recognise specific modified residues on H3 and H4 histone tails were all purchased from Millipore (Bedford, MA, USA). Primary antibody incubation was carried out at 4°C overnight, followed by washes and incubation with a secondary horseradish peroxidase-labelled goat anti-rabbit antibody (GE Healthcare, Piscataway, NJ, USA) for 1 h at RT. Membranes were washed and immunolabelled proteins were visualised with enhanced chemiluminescence detection reagent (GE Healthcare). Quantitative densitometric analysis was performed using NIH IMAGE (Bethesda, MD, USA). All modified histone levels were normalised to that of total H3 histone (Millipore) to account for the loading variation. Statistical significance was calculated by one-way ANOVA followed by Dunnett's multiple comparison test using GRAPHPAD PRISM (GraphPad Software Inc., San Diego, CA, USA). Progesterone receptor protein was detected in the same extracts using rabbit monoclonal antibody that recognises both PgR-A and PgR-B isoforms (clone SP2; Thermo Fisher Scientific). PgR levels were normalised to that of b-actin (Santa Cruz Biotechnology; Santa Cruz, CA, USA).
ChIP and quantitative polymerase chain reaction (qPCR)
The ChIP assay was performed using EZ-Magna ChIP kit (Millipore) in accordance with the manufacturer's instructions, with some modifications. Briefly, VMH and POA tissue collected from Veh and E 2 -treated mice was cut into approximatey 1-mm pieces and crosslinked in 1% formaldehyde at RT for 15 min. To perform ChIP with ERa antibody (Clone: TE111.5D11; Thermo Fisher Scientific), an additional cross-linking step with 2 mM ethylene glycol-bis(succinimidylsuccinate) (Thermo Scientific) was introduced, followed by 30 min with 1% formaldehyde (37) . Tissue from two to four mice was pooled for each sample. After quenching and washing out the formaldehyde, tissue was homogenised in 1% SDS nuclear lysis buffer containing protease inhibitors. Chromatin was sheared using Bioruptor sonicator (Diagenode Inc., Denville, NJ, USA), cleared by centrifugation and the protein concentration was determined using BCA protein assay kit (Thermo Fisher Scientific). An equal amount of chromatin (300 lg) was used from each sample to immunoprecipitate H3Acetyl and H3K4me3 using antibodies that recognise pan-acetylated H3 (06-599) and specific trimethylated H3K4 residue (07-473) (both Millipore). In total, 10% of each sample amount (30 lg) was removed and saved as input. For immunoprecipitating ERa, 1 mg of chromatin was used for each sample and 5% of sample amount was saved as input. The specificity and efficiency of ERa antibody is shown in Figure S2 . After several washes, pulled-down complexes were reverse cross-linked and genomic DNA was purified. Quantitative PCR was used to measure the amount of immunoprecipitated DNA and C t values obtained were normalised to those from input. Statistical significance was calculated by one-way ANOVA followed by Dunnett's multiple comparison test using GRAPHPAD PRISM. The sequences and positions of primers used to detect binding of modified H3 histones to Pgr and Oxtr promoters are listed in Tables 1 and 2 , respectively, and are based on sequences of the mouse Pgr (accession number U12644) and Oxtr gene (accession number D86631). The sequences and positions of primers used to detect binding of ERa to the upstream putative enhancer regions of the mouse Pgr gene are listed in Table 3 +621/+683 Forward 5′-GGAG CTTGG GT CG TCATGA -3′ Reverse 5′-GCCAGA CGT GTGGAGA AC CT-3′ Prom4 +841/+915 Forward 5′ -AGCTCC CAG ACGGAAAG ACA-3′ Reverse 5′-GTG GC TTCTACCC CAGAGAAAG -3′ 
Results
Oestradiol induces global changes in histone modifications in the VMH
To determine the effects of E 2 treatment on chemical modifications of histone proteins in the VMH of female mice, we first investigated the changes and the time course of total histone modifications in this brain region following E 2 administration. Ovariectomised (OVX) female mice were injected with E 2 (20 lg) or Veh and the brains were analysed 1, 3, 6 and 9 h later. The dose of E 2 was chosen to correlate the molecular and biochemical effects of the hormone with the expression of lordosis behaviour, which, in our experience, requires higher doses of E 2 when used independently of progesterone priming (39) . Because the sustained dose-response range for E 2 is extremely wide (40) , a dose of 20 lg is considered to be within the physiological range. Total extracts of VMH tissue were isolated from E 2 and Veh-treated mice and analysed by Western blotting using antibodies that recognise specific chemically modified histone residues. We measured global acetylation levels of histone H3 and H4 (H3Ac and H4Ac), trimethylation levels of H3K4, H3K36 and H3K9 (H3K4me3, H3K36me3 and H3K9me3), as well as double phosphorylation/acetylation marks on histone H3 (H3S10phK14Ac) (Fig. 1) . Acetylation of Lys residues on histone H3 and H4 is a wellcharacterised modification that leads to an open chromatin structure and promotes transcription (41) . Methylation of H3K4 and H3K36 residues is also associated with transcriptional activation, whereas methylation of H3K9 is generally regarded as a repressive histone mark (41) . Moreover, as an example of cross-regulation of histone modifications, H3S10 phosphorylation has been shown to promote H3K14 acetylation in several experimental systems and is linked to transcriptional activation (42-44).
In the VMH of female mice, levels of total histone modifications were highly regulated following E 2 administration. Antibody that recognises double modification H3S10phK14Ac detected significant changes in the levels of this combinatorial histone mark. One-way ANOVA revealed a significant main effect of time of treatment (F 4,93 = 2.482, P = 0.049) and a post-hoc Dunnett's multiple comparison test showed a significant increase 1 h after E 2 administration. However, H3S10phK14Ac appeared to be transient and, by 6 h following E 2 injection, the levels returned to baseline (Fig. 1A) . Antibody that recognises H3 pan-acetylation detected significant changes following E2 injection (one-way ANOVA: F 4,110 = 4.813, P = 0.001). In contrast to H3S10phK14Ac, total H3 acetylation detected by H3 pan-acetyl antibody increased with slower kinetics and reached significantly higher levels only 6 h after E 2 treatment according to a Dunnett's multiple comparison test (Fig. 1B) . Another activating histone modification, H3K4me3, is also regulated in the VMH of female mice following E 2 administration. One-way ANOVA revealed a significant main effect of time of treatment (F 4,100 = 3.944, P = 0.005) and a post-hoc Dunnett's multiple comparison test showed significantly higher levels 3 and 6 h following E 2 administration (Fig. 1C ). An interesting pattern of changes was observed in the level of repressive H3 histone modification, H3K9me3. One-way ANOVA revealed a significant main effect of time of treatment (F 4,49 = 15.40, P < 0.0001) and a post-hoc Dunnett's multiple comparison test demonstrated significant changes at all time points examined. Specifically, levels of H3K9me3 were significantly increased at the beginning (1 h) and towards the end (9 h) of the investigated E 2 time course and significantly decreased 3 and 6 h after injection. This decrease of H3K9me3 coincides with the significant up-regulation of H3K4 trimethylation (Fig. 1D) . Interestingly, these data are in line with previous studies indicating that these two methylation events are mutually exclusive (42, 45) . We failed to detect any changes in the levels of H3K36me3, an active chromatin mark on histone H3 (one-way ANOVA: F 4,63 = 1.699, P = 0.161) (Fig. 1E) . Finally, analysis of total acetylation levels of 
*Boney-Montoya et al. (35) . ERE, oestrogen response element.
histone H4 revealed a significant main effect of time of treatment (one-way ANOVA: F 4,117 = 4.051, P = 0.0041) and a post-hoc Dunnett's multiple comparison test showed that H4 acetylation was significantly decreased 9 h following E 2 injection (Fig. 1F ).
These data revealed that, in the female mouse, VMH E 2 treatment induces rapid changes in the covalent modifications of histone H3 tail residues. Moreover, specific modifications appear to be sequential and follow distinct temporal patterns. Collectively, these cova- 
Oestradiol (E 2 ) effects on the levels of histone modifications in the ventromedial nucleus of the hypothalamus (VMH) of female mice. Ovariectomised female mice were injected with E 2 or vehicle (Veh) and their brains were collected for the analyses 1, 3, 6 or 9 h later. The levels of histone modifications in VMH tissue were measured by Western blotting using antibodies that recognise specific modified residues: H3S10phK14Ac (A), H3 Acetyl (B), H3K4me3 (C), H3K9me3 (D), H3K36me3 (E) and H4 acetyl (F). Levels of each histone modifications were normalised to that of total histone H3. A representative Western blot for each histone modification examined is shown. Data reported are the mean of three to four independent experiments performed in triplicate. Data are expressed as the fold change (mean AE SEM). Statistical differences were calculated using one-way ANOVA with a post-hoc Dunnett's multiple comparison test. *P < 0.05, **P < 0.01. lent histone modifications establish a favourable environment for the transcriptional activity in the VMH of female mice within 3-6 h of E 2 treatment.
E 2 -induced histone modifications are accompanied by ERa target gene up-regulation
The Pgr gene is a classic ERa target gene, which is regulated by E 2 in several tissues (46) (47) (48) . Thus, we tested whether the E 2 -induced 'permissive chromatin' state in VMH leads to the up-regulation of PgR expression. As expected, protein levels of both PgR isoforms, PgR-A and PgR-B, were significantly increased following E 2 administration (Fig. 2B,C) . One-way ANOVA revealed a significant main effect of treatment (F 4,70 = 5.866, P = 0.0004 for PgR-A and F 4,68 = 10.88, P < 0.0001 for PgR-B) and a post-hoc Dunnett's multiple comparison test showed significantly higher levels of both isoforms 6 h after hormone injection, coinciding with the E 2 -induced H3 acetylation and H3K4 methylation events.
To confirm that our chosen dose of E 2 was within the physiological range, we performed a control experiment in which PgR protein levels were also examined in VMH tissue of OVX female mice injected with 2 lg of E 2 . A low dose of E 2 , similar to the effect seen with a higher dose, led to significant induction of PgR protein 6 h after injection (see Supporting information, Fig. S1 ).
These data reveal that, in the VMH of female mice, an 'active' chromatin state brought about by E 2 exposure coincides with the transcriptional activation of an ERa target gene, Pgr, and may contribute to its regulation.
E 2 treatment induces association of activating histone marks with Pgr promoter in the VMH
To investigate how E 2 -induced histone modifications contribute to the expression of the Pgr gene in the VMH of female mice, we examined the association of acetylated (H3Ac) and methylated (H3K4me3) histone H3 with the promoter of this gene using a ChIP assay. OVX female mice were injected with E 2 and Veh and brains collected 3 and 5 h later. The time-points to detect 'activating' histone marks at the regulatory sequences of the Pgr gene were selected to precede E 2 -induce PgR protein up-regulation. Chromatin isolated from VMH tissue of E 2 and Veh-treated mice was immunoprecipitated using antibodies specific for H3Ac and H3K4me3. It has been shown that H3 histone acetylation and H3K4 methylation most often take place near the TSS of actively transcribed genes (49, 50) . Although the 5′ sequence of mouse Pgr gene has been reported (33) , the functional analysis of mouse Pgr promoter has not been performed. On the other hand, the existence of two functional promoters for PGR-A and PGR-B isoforms has been described for rat and human PGR genes (31, 32) . Using sequence alignment, we mapped two regions within an approximately 2-kb sequence around the mouse Pgr TSS, which display close to 83% sequence identity with the rat Pgr gene promoters (Fig. 3A) . Thus, four primer pairs (designated Prom1-4; Table 1 ), spanning the region between À720 and +915 bp relative to the TSS, were designed to analyse association of H3Ac and H3K4me3 with mouse Pgr gene promoter. Both H3Ac and H3K4me3 were enriched at the promoter sequences of the Pgr gene in the VMH of E 2 -treated female mice compared to control mice. One-way ANOVA analysis revealed significant main effect of treatment on H3Ac at three promoter sites of the Pgr (Fig. 3B) . Another histone mark leading to an open chromatin confirmation, H3K4me3, was also significantly up-regulated at Pgr gene promoter in the VMH of E 2 -treated female mice at two promoter sites (Prom1, F 2.31 = 5.776, P = 0.007; Prom4, F 2,31 = 5.611, P = 0.008). A post-hoc Dunnett's multiple comparison test revealed a significant increase in H3K4me3 associated with the Prom1 and Prom4 sites, which span the Pgr-B and Pgr-A promoters, respectively, 5 h after E 2 injection (Fig. 3C ). These data suggest that the mechanism by which E 2 -activated ERa induces the transcription of the Pgr gene in mouse brain involves histone modifications and changes to chromatin structure at the promoter of this target gene.
E 2 affects histone modifications at the Pgr promoter in the POA
It has been well documented that E 2 regulates PgR expression in some brain regions but not others (37) . One of the brain regions responsive to E 2 treatment is the POA. Thus, we examined histone modification status at Pgr gene promoter in the POA of female mice using a ChIP assay. One-way ANOVA analyses revealed significant effects of E 2 treatment on the associations of H3Acetyl with two promoter sites of the Pgr gene (Prom2, F 2,29 = 3.370, P = 0.048; Prom4, F 2,32 = 4.4, P = 0.021). We also observed a significant increase in the H3K4me3 levels at the most distal promoter site of the Pgr gene (Prom1, F 2,30 = 15.24, P < 0.0001) (Fig. 4A,B) . A post-hoc Dunnett's multiple comparison test revealed that both histone modifications (H3Acetyl and H3K4me3) were up-regulated in the VMH of female mice only 5 h after E 2 injection with no changes detected at the 3-h time point (Fig. 4A,B ). These results demonstrate that the time course and pattern of E 2 -induced histone modifications at the promoter of the Pgr gene is brain-region specific and may reflect the differences in the expression of PgR in these nuclei. E 2 differentially affects histone modifications at Oxtr promoter in the POA and VMH One of the gene products regulated by E 2 that facilitate the expression of lordosis behaviour is oxytocin receptor (51, 52) . Thus, we examined how E 2 treatment affects histone modifications at the promoter of the Oxtr gene in two brain regions, the VMH and POA of female mice. Three primer pairs (Oxtr prom1-3; Table 2 ) that span an approximately 600-bp sequence in the 5′ untranslated region (UTR) of the mouse Oxtr gene were designed and used to detect the association of acetylated and methylated histone H3 with the regulatory region of this gene (Fig. 5A) . We observed different patterns and time-courses of E 2 -mediated regulation of H3Ac and H3K4me3 at the promoter of Oxtr gene in the two brain regions (Fig. 5B) . In the mouse VMH, one-way ANOVA analysis revealed a significant effect of E 2 treatment on both 'activating' histone marks, H3Acetyl and H3K4me3, albeit to a different degree. Histone H3 hyperacetylation was detected at two promoter sites of Oxtr gene (Oxtr prom2, F 2,27 = 3.770, P = 0.036; Oxtr prom3, F 2,31 = 5.118, P = 0.0120) and H3K4 trimethylation was increased at single promoter site (Oxtr prom2, F 2,32 = 3.575, P = 0.04) (Fig. 5B) . Furthermore, a post-hoc Dunnett's multiple comparison test failed to detect significant changes in H3Ac or H3K4me3 at any one of the specific sites of 5′ UTR of Oxtr gene 3 h after E 2 administration but revealed significant up-regulation of H3Acetyl and H3K4me3 at the 5-h time point (Fig. 5B ).
In the mouse POA, one-way ANOVA analysis revealed the effect of E 2 treatment on H3Ac association with all three Oxtr promoter sites (Oxtr prom1, F 2,32 = 8.565, P = 0.001; Oxtr prom2, F 2,32 = 6.471, P = 0.004; Oxtr prom3, F 2,33 = 3.846, P = 0.032) and a post-hoc Dunnett's multiple comparison test demonstrated significant hyperacetylation taking place at Oxtr prom1 and Oxtr prom2 only 5 h after E 2 administration (Fig. 5C) . No changes were detected in the POA in the methylation status of H3K4 at any Oxtr promoter sites following E 2 administration. These results suggest that E 2 treatment induces distinct covalent modifications of histone H3 in the brains of OVX female mice in a gene-(Oxtr 6 ¼ Pgr) and region-(POA 6 ¼ VMH) dependent manner.
Effects of E 2 on the recruitment of ERa to the putative regulatory sequences on Pgr gene E 2 regulates the transcriptional activity of target genes by binding to one of the two nuclear ERs, ERa and ERb. Overwhelming evidence indicates that induction of the Pgr gene in the VMH of female mice and subsequent expression of lordosis behaviour critically requires ERa (12, 14) . Thus, we set out to examine whether E 2 treatment of OVX female mice results in the direct recruitment of ERa to the promoter of Pgr gene. For this, OVX female mice were injected with Veh or E 2 and chromatin isolated from the VMH 5 h later was analysed using a ChIP assay. The time-point to analyse the association of ERa with the regulatory sequences of the Pgr gene was selected to precede E 2 -induce PgR protein up-regulation.
Reportedly, there are no consensus ERE sites within the promoter region of mouse Pgr gene; however there is a half ERE site within the Pgr-A promoter (Fig. 3A) . Furthermore, recent studies suggest that several sequences approximately 150-300 kb upstream of human PGR gene contain ERE sites and act as enhancers to regulate PGR gene expression (35) . Examination of approximately 200-kb genomic sequences upstream of mouse Pgr gene led to identification of seven ERE sites, which displayed high homology to the ERE sites characterised by Boney-Montoya et al. (35) in human as well as in mouse genomes (Dr Ann Nardulli, personal communication). Thus, we examined the direct association of ERa with these putative regulatory sequences of Pgr gene: four sites within the proximal promoter region (Fig. 3A and Table 1 ) and seven ERE-containing sites within approximately 200 kb upstream of the TSS (Fig. 6A and Table 3 ). In concert with previous studies, we did not observe E 2 -regulated recruitment of ERa to the promoter region of the Pgr gene (28) . We did, however, detect E 2 -induced binding of ERa at two putative enhancer regions located approximately 81 and 200 kb upstream of the Pgr gene TSS (Fig. 6B) . Statistical analysis using Student's t-test revealed a significant increase in the binding of ERa 5 h after E 2 administration only at enhancer 4 site (P = 0.043). This is the first evidence that the ERE-containing site 200 kb upstream of Pgr TSS may be involved in the regulation of the Pgr gene by ligand-activated ERa in the mouse brain in vivo. Surprisingly, little or no E 2 -induced recruitment of ERa was observed at any other ERE sites following E 2 administration (Fig. 6B) , suggesting that, contrary to data obtained in human breast cancer cells (28, 35) these ERE-containing sites are not involved in the regulation of Pgr gene expression in the mouse brain. These data suggest that different regulatory sequences contribute to Pgr gene activation in different species.
Effects of E 2 on the expression of ERa cofactors in the VMH of female mice trimethylation at the promoter of the Pgr gene in the POA of female mice were determined using a chromatin immunoprecipitation assay. Data reported are the mean of three independent experiments performed in triplicate. Data are expressed as percentage vehicle (Veh) (mean AE SEM). Statistical differences were calculated using one-way ANOVA with a post-hoc Dunnett's multiple comparison test. *P < 0.05; **P < 0.01.
ability of histone-modifying enzymes (53) . Although a large number of ERa cofactors with HAT or HMT activity has been identified in human cancer cells, little or no information exists regarding which of these cofactors regulates the transcriptional activity of ERa in the nervous tissue. Thus, we examined the mRNA expression levels of some of transcriptional coregulators, which are able to bring about histone modifications that we detected in the VMH following E 2 treatment. For this, OVX female mice were injected with E 2 and Veh and the brains were analysed 3 or 5 h later. Total RNA was isolated from the VMH and POA tissues, reverse transcribed and the resultant cDNA was used as a template for qPCR. Expression of each gene of interest was normalised to that of a housekeeping gene (ribosomal 18S gene) and the relative ratio between the Veh and E 2 -treated samples was calculated as described in the Materials and methods. Among the examined factors were SRC1, SRC2, CBP and p300, comprising well-characterised ERa coactivators with HAT activity, which are involved in ER-mediated transcriptional activation in various tissues, including the brain (15,30); MLL1 and MLL3, two important HMTs, which specifically modify H3K4 residue and are involved in the E 2 -regulated expression of various HOX genes in human MCF-7 cells (20); WDR5, an essential DNA-binding subunit of MLL complexes (54,55); ASH1L, a H3K4 methyltransferase, not yet characterised as an ERa coregulator (55); LSD1, a coregulator with the activity to demethylase both H3K4 and H3K9, and thus either repress or promote nuclear receptor-mediated transcription (56,57); and JARID1A, which has been shown to regulate E 2 -induced PGR expression in human MCF-7 cells through H3K4 demethylation (58) . We found that E 2 treatment induced significant changes in the levels of histone-acetylating cofactor mRNAs in the VMH of female mice (Fig. 7) . The expression of two Src isoforms, Src1 and Src2, was highly regulated by E 2 -exposure as revealed by one-way ANOVA A small arrow indicates the translation start site. Histone H3 acetylation and H3K4 trimethylation at the promoter of mouse Oxtr gene in (B) the VMH and (C) the POA of female mice were determined using a chromatin immunoprecipitation assay. Data reported are the mean of three independent experiments performed in triplicate. Data are expressed as percentage vehicle (Veh) (mean AE SEM). Statistical differences were calculated using one-way ANOVA with a post-hoc Dunnett's multiple comparison test. *P < 0.05; **P < 0.01.
(Src1, F 2,29 = 4.255 P = 0.024; Src2, F 2,28 = 11.04 P = 0.0003). A post-hoc Dunnett's multiple comparison test revealed significant up-regulation of both Src isoforms at the 3-h time point; however, 5 h after E 2 administration, Src1 stayed elevated, whereas Src2 mRNA levels returned to baseline. The other two homologous ER cofactors with HAT activity, CBP and p300, also displayed somewhat different patterns of changes. One-way ANOVA revealed a significant main effect of treatment on the expression of p300 (F 2,28 = 22.07, P < 0.0001) but not on the expression of Cbp (F 2,29 = 2.247, P = 0.124). A post-hoc Dunnett's multiple comparison test demonstrated a transient pattern of p300 up-regulation, which reached significantly high levels at 3 h and returned to baseline 5 h after E 2 injection (Fig. 7A) . The mRNA expression of two HMTs, Mll3 and Ash1, as well as the accessory protein, Wdr5, was also regulated by E 2 in the VMH of OVX female mice (Fig. 7B) . One-way ANOVA revealed a significant effect of treatment on the expression of Mll3 (F 2,31 = 4.204, P = 0.0242), Ash1 (F 2,31 = 8.141, P = 0.0014) and Wdr5 (F 2,30 = 8.726, P = 0.001). Moreover, a post-hoc Dunnett's multiple comparison test revealed differential temporal patterns of induction: the increase in the levels of Ash1 and Wdr5 mRNA levels was transient, with these being detected at the 3-h time point and returning to baseline after 5 h; Mll3 mRNA up-regulation was delayed and only reached significant levels 5 h following E 2 administration (Fig. 7B) . Interestingly, no changes were detected in the mRNA levels of Mll1 (Fig. 7B) .
The mRNA expression of the two examined histone demethylases (HDMs) was also regulated by E 2 exposure in the VMH of female mice (Fig. 7C) . One-way ANOVA revealed a significant effect of treatment on the expression of Lsd1 (F 2,28 = 3.715, P = 0.0371) and Jarid1A (F 2,32 = 4.59, P = 0.0177). However, a post-hoc Dunnett's multiple comparison test only detected significant down-regulation of Lsd1 at 3 h, whereas the increase in Jarid1A mRNA detected at the same time point was not significant (Fig. 7C) .
Effects of E 2 on the expression of ERa cofactors in the POA of female mice Because (i) we detected differential acetylation and methylation events occurring at the promoters of ERa target genes in the two brain regions, VMH and POA and (ii) we hypothesise that differential regulation and expression levels of ERa cofactors may underlie these effects, we therefore examined the mRNA expression levels of given cofactors in the POA of OVX female mice following E 2 administration. Interestingly, we found that in POA (35) . Black diamonds denote oestrogen response element (ERE) sites that are conserved between human and mouse enhancer sequences. Locations of primers used to amplify sequences within promoter region (Prom1-4) are as shown in Fig. 3(A) . (B) Chromatin isolated from oestradiol (E 2 ) and vehicle (Veh)-treated mice was immunoprecipitated with antibody specific for ERa and associated genomic DNA was quantified by a quantitative polymerase chain reaction. Data are expressed as percentage Veh (mean AE SEM) and represent the mean of two independent experiments performed in triplicate. Statistical differences between E 2 and Veh-treated samples were calculated using Students's t-test. *P < 0.05.
mRNA levels of examined HATs, HMTs and HDMs were more stable and less dynamically regulated by E 2 -exposure compared to the VMH. Specifically, we found that, in the POA of female mice, Src1 and Src2 mRNA levels do not change following E 2 administration (Fig. 8A) . By contrast, there was a significant effect of treatment on the mRNA expression of Cbp (F 2,31 = 8.139, P = 0.0014) and p300 (F 2,34 = 4.786, P = 0.0147) as revealed by one-way ANOVA. Furthermore, a post-hoc Dunnett's multiple comparison test showed a significant down-regulation of Cbp 5 h after E 2 treatment and a similar trend for p300, although this failed to reach statistical significance (Fig. 8A) .
Among the factors involved in H3K4 methylation, the effect of E 2 on mRNA expression was only observed for Ash1 (F 2,31 = 4.196, P = 0.0244) 5 h after E 2 administration, as revealed by one-way ANOVA. In contrast to the data obtained from the VMH, the expression of Jarid1A but not Lsd1 was regulated by E 2 administration in the POA (F 2,32 = 4.222, P = 0.0236) (Fig. 8C) .
Taken together, these data demonstrate that one of the mechanisms by which E 2 induces changes in the chemical makeup of histone proteins in the mouse brain includes the regulation of histone-modifying cofactor mRNA expression. These data also support the hypothesis that the tissue-specific effects of E 2 -activated ERa may be mediated by the availability of transcriptional cofactors.
Discussion
The present study shows that, in a specific hypothalamic region important for lordosis behaviour, exposure to oestradiol induces a specific set of histone modifications with distinct temporal characteristics. Moreover, E 2 -induced histone modifications are detected at the level of global chromatin, as well as at the promoters of ERa target genes, and provide mechanistic insight into the early molecular events underlying hormonal effects on nervous tissue. Oestradiol (E 2 ) effects on the mRNA expression levels of histone-modifying factors in the VMH. Total RNA isolated from E 2 and vehicle (Veh)-treated mice was reverse transcribed and the expression levels of oestrogen receptor (ER)a cofactors, histone acetyltransferases (A), histone methyltransferases (B) and histone demethylases (C), were analysed by a quantitative polymerase chain reaction. Data are expressed as the fold change (mean AE SEM) and represent the mean of two independent experiments (n = 5 for each). Statistical differences were calculated using one-way ANOVA followed by a post-hoc Dunnett's multiple comparison test. *P < 0.05, **P < 0.01. HATs, histone acetyltransferases; HDMs, histone demethylases; HMTs, histone methyltransferases.
In the VMH of female mice, E 2 induces specific set of histone modifications
Acetylation of histone proteins has long been known to promote transcriptional activity and contribute to E 2 -induced gene expression in human MCF-7 cells (50, 59) . Moreover, evidence supports the importance of histone acetylation in E 2 -mediated behavioural and physiological processes, such as the masculinisation of sexual behaviour and formation of hippocampus-dependent memory in mice (60, 61) . Our preliminary data also suggest that histone hyperacetylation induced by histone deacetylase inhibitor, trichostatin A treatment, is able to facilitate E 2 -induced sexual behaviour in female mice (see Supporting information, Fig. S3 ). Thus, it was not surprising that we observed an increase in the acetylation of histone H3 in the VMH of E 2 -treated mice. By contrast, we did not find an increase in the levels of histone H4Ac, but rather detected a slight albeit significant decrease at the 9-h time point. Such differences in the patterns of H3 and H4 acetylation appear to be a characteristic early response to E 2 action specifically in the mouse brain. For example, in another brain region, the hippocampus, direct infusion of E 2 also resulted in the acetylation of H3 but not of H4 histone, whereas E 2 treatment of human MCF-7 cells does lead to H4 acetylation at the level of total chromatin, as well as at ERa target gene promoters demonstrating tissue-specific epigenetic effects of E 2 (60, 62) . In addition, we have found that, in the VMH of female mice, E 2 administration induces a rapid phosphorylation/acetylation event on histone H3, H3S10ph/H3K14Ac. These two cis modifications on histone H3 have been shown to occur in a cooperative fashion, with phosphorylation of H3S10 promoting subsequent acetylation of Oestradiol (E 2 ) effects on the mRNA expression levels of histone modifying factors in the preoptic area (POA). Total RNA isolated from E 2 and vehicle (Veh)-treated mice was reverse transcribed and the expression levels of oestrogen receptor (ER)a cofactors, histone acetyl transferases (A), histone methyl transferases (B) and histone demethylases (C), were analysed by a quantitative polymerase chain reaction. Data are expressed as the fold change (mean AE SEM) and represent the mean of two independent experiments (n = 5 for each). Statistical differences were calculated using one-way ANOVA followed by a post-hoc Dunnett's multiple comparison test. *P < 0.05, **P < 0.01. HATs, histone acetyltransferases; HDMs, histone demethylases; HMTs, histone methyltransferases.
H3K14 (45, 46) . Interestingly, E 2 -induced acetylation of H3 (on H3K14) in the mouse hippocampus has been shown to critically depend on ERK activation (60), whereas, in human MCF-7 cells, E 2 also induced H3S10 phosphorylation in a MEK1 kinase-dependent manner (62) . Based on this evidence, we can infer that a phosphorylation event, possibly of H3S10, by mitogen-activated protein kinase may be a prerequisite for H3K14 acetylation and a common mechanism for E 2 -induced epigenetic effects.
In the VMH of female mice, E 2 administration also led to a significant increase in the levels of H3K4me3, another 'permissive' histone modification, which has been shown to be important for the transcriptional activity of ERa in human breast cancer cell model (28) . In addition, our data support the previous finding that H3K4 and H3K9 methylation marks are mutually exclusive (45, 48) : at 3 and 6 h after E 2 administration, the levels of H3K4me3 in the VMH are significantly increased, whereas levels of H3K9me3 are dramatically decreased. These data, in conjunction with the marked elevation of H3 histone acetylation 6 h following E 2 injection, suggest that, in this behaviourally critical hypothalamic nucleus, hormone treatment induces rapid changes in the make-up of histone proteins. As a result, the combinatorial effect of these changes creates a permissive environment for the transcriptional activity within a distinct time window.
Our analyses also revealed some unexpected results. Notably, in the VMH of female mice, we detected a significant up-regulation of repressive H3K9 methylation within 1 h of E 2 administration, as well as 9 h after E 2 injection, just when the effects of hormones on histone H3 acetylation and H3K4me have worn off. It is well established that E 2 treatment leads to the down-regulation of a number of genes in various mouse tissues (63, 64) . Moreover, microarray analysis of E 2 -regulated genes in mouse uterine tissue had revealed distinct temporal patterns of target gene activation as well as repression (64) . Specifically, approximately 17% of total genes identified by Watanabe et al. (64) were down-regulated by E 2 treatment within the first hour. Among these were genes coding for signal transduction molecules and transcription factors, indicating that their rapid down-regulation may lead to further amplification of the effects of E 2 . Our data suggest that similar mechanisms may be in place in the VMH as well; however, further studies are needed to examine the precise role of ERa repressed genes on the CNS function and physiological outcomes of E 2 treatment. On the other hand, the marked increase in the levels of H3K9me3, together with significant down-regulation in the basal levels of H4 acetylation, 9 h after E 2 -exposure, may be indicative of termination of the effects of E 2 on VMH cells.
The pattern of E 2 -induced histone modifications at the promoters of target genes is brain-region and gene-specific
We used the ChIP assay to extend our analyses and examine E 2 -effects on the histone modifications at the promoters of specific ERa-target genes, Pgr and Oxtr, in two hormone-responsive brain regions, the VMH and POA. Our data revealed interesting brainregion and gene-specific effects of E 2 treatment (Table 4) . Specifically, we found differences in the pattern and the time-course of histone H3 acetylation associated with the Pgr gene promoter in the two nuclei: rapid and sustained hyperacetylation (H3Ac) in the VMH and delayed and less pronounced H3Ac in the POA. These data are in agreement with a study demonstrating anatomic specificity of PgR regulation by E 2 in the rodent brain (25) . By contrast, the degree and time-course of E 2 -induced H3K4 methylation at Pgr the promoter was found to be similar in both the VMH and the POA, indicating the importance of this specific histone modification in the regulation of the Pgr gene. Moreover, methylation of H3K4 in response to E 2 appears to be a common requirement for the expression of the Pgr gene across tissues because knockdown of Mll1, the methyltransferase responsible for this modification, leads to a thwarted effect of E 2 in human MCF-7 cells as well (28) .
Interesting gene-specific effects were observed when we analysed histone modifications associated with the Oxtr promoter (Table 4) . In contrast to Pgr, H3 histone acetylation appeared to be more prominently regulated by E 2 -exposure at the promoter of this specific ERa-target gene, whereas little or no changes in the levels of H3K4me were detected. Moreover, an increase in the levels of H3Ac at the Oxtr promoter was only detected 5 h following treatment and this effect was evident in both hypothalamic nuclei examined, the POA and VMH. Such delayed kinetics of 'activating' histone modifications associated with Oxtr promoter may reflect the time course of E 2 -induced OXTR expression, which only becomes detectable in the VMH after 6 h and reaches significant levels at 24 h (65). These data suggest that the temporal regulation of early epigenetic events, such as covalent histone modifications induced by E 2 treatment, may be the determining factor of the time course of gene induction.
E 2 regulates the expression of transcription cofactors in a brain-region specific manner
Transcription factors, such as nuclear receptors, recruit coregulators with intrinsic histone acetyltransferase and histone methyltransferase activity to induce specific histone modifications at the regulatory sequences of target genes (15) . It has been postulated that regulation of cofactor expression levels and availability is one of the mechanisms that impacts histone modifications and chromatin structure (52, 53) . Our data, demonstrating that E 2 -exposure significantly up-regulates mRNA levels of several ERa cofactors with HAT (15) . However, only few of these have been functionally tested in the nervous system. Among them, two SRC isoforms, SRC1 and SRC2, were shown to be co-expressed with ERa in hormone responsive brain regions, physically interact with the receptor and be required for E 2 -dependent expression of the Pgr gene and reproductive behaviours (29, 30) . The important role of SRC1, as well as another ERa cofactor with HAT activity, CBP, has also been demonstrated in the development of sexually dimorphic behaviours during the perinatal period in female rats (66) . In the present study, we found that, following E 2 administration, mRNA levels of two Src isoforms (1 and 2), as well as p300, are increased in the VMH of female mice. Interestingly, the observed up-regulation of cofactor mRNA either coincided or preceded H3 histone acetylation events detected at the level of total chromatin and at the promoters of ERa-target genes. Although we have not explored the causal relationship between HAT mRNA induction and histone acetylation detected in the VMH of female mice, the time-courses of these two events lead us to suggest a cause-effect connection (Fig. 7) . Among the examined HATs, the E 2 -induced increase in mRNA levels of Src2 and p300 was very rapid and transient, detected only at 3 h and gone by the 5-h time point. Src1 was the only co-activator that was persistently elevated following E 2 treatment, suggesting possible functional specificity of this isoform. These results also emphasise the importance of the time-scale of experimental design. When studying the effects of E 2 on the brain, molecular mechanisms and correlates are often investigated at the same time-scale as behavioural outcomes, 24 or 48 h after E 2 treatment. Our study was specifically designed to investigate early molecular events, which take place over the scale of a few hours. These differences may be the bases for the discrepancies between our findings showing that Src1 and Src2 mRNA levels in VMH are regulated by E 2 , and previous reports that failed to detect such regulation 24 h after E 2 treatment (67). Although several histone methyltransferases have been shown to contribute to ERa transcriptional activity in MCF-7 cells, the importance of H3K4me and its modifying enzymes in E 2 -mediated effects on the CNS have not been addressed. In the present study, we detected a significant increase of mRNA levels of two HMTs, Mll3 and Ash1, as well as an essential subunit of the MLL complex, Wdr5, in the VMH, following E 2 administration. The time course of the increase in HMT mRNA expression coincided with the H3K4 methylation events at the promoters of Pgr and Oxtr in the VMH of female mice, once again suggesting a causal relationship. Interestingly, MLL1 was shown to be one of the factors required for the expression of the PGR gene in human MCF-7 cell (28); however, we did not observe any changes in the levels of this specific HMT. These data suggest that the effect of MLL1 on Pgr expression may be tissue specific and that another isoform, MLL3, which is persistently up-regulated in VMH by E 2 , is important for Pgr regulation in the brain. Alternatively, in the brain, E 2 may affect the recruitment of MLL1 to the promoter of the Pgr gene without altering its levels, and further studies will aim to address this possibility. Nonetheless, significant up-regulation of Wdr5, a common DNA-binding subunit of both MLL1 and MLL3 complexes, in the VMH of female mice, indicates the important role of these HMT complexes in E 2 -induced transcriptional regulation. Interestingly, it has been reported that genetically-modified female mice, which express catalytically inactive MLL3 (Mll3  ) were infertile and males with the same mutation were hypofertile (68) . Although no detailed characterisation of this phenotype was provided, given the critical requirement of ERa transcriptional activity for the female reproduction, both at the level of reproductive tissues as well as at the level of the hypothalamic behavioural circuit, we can hypothesise that the infertility observed in these mutant mice was a result of disruptions in E 2 -signalling. Moreover, MLL complexes have been previously implicated in the development and various functions of the rodent nervous system, such as nerve cell differentiation, adult neurogenesis and memory formation (69) (70) (71) , which emphasises the importance of studying the role of these epigenetic factors in the brain.
It has been suggested that tissue-and gene-specific effects induced by ligand-activated ERs may be mediated through differential recruitment or expression of coregulator proteins. In the present study, we tested whether brain-region specific histone modifications (H3 acetylation and H3K4 methylation), which we detected at the promoters of Pgr and Oxtr genes in the VMH and the POA, may be the result of differential expression of ERa cofactors. Our results, showing vast differences in the mRNA expression of several histone-modifying cofactors between these nuclei, confirmed this hypothesis. Although mRNA expression of most cofactors with HAT or HMT activity was significantly up-regulated in the VMH of female mice, we observed either no change or, in a few cases, a decrease in the levels of these factors in the POA (Figs 7  and 8 ). These data indicate that, in the POA, E 2 -induced histone acetylation and H3K4 methylation at the promoters of Pgr and Oxtr genes does not require the activity of given coregulators. Alternatively, E 2 -induced histone modifications in these brain regions may be the result of the differential recruitment of these factors to the regulatory sequences of the Pgr and Oxtr genes. In conclusion, based on our results, we propose that E 2 -activated ERa may employ differential epigenetic mechanisms to induce brain-region specific transcription of target genes in the VMH and the POA of female mice. E 2 -regulated recruitment of ERa to the putative regulatorysequences is different between human and mouse Although it is well established that Pgr gene expression is directly regulated by ligand-activated ERa, we failed to convincingly demonstrate the recruitment of ERa to the regulatory sequences on the Pgr gene. There is no ERE site within the promoter region of either mouse Pgr or human PGR genes. Alternatively, it was suggested that half-ERE and proximal Sp1 or AP-1 sites may be sufficient for ERa recruitment to human PGR gene promoter (72, 73) . More recent studies have shown that ERa does not bind within the promoter region of human PGR gene but is rather recruited to the remote enhancer sequences as far as 300 kb upstream of the TSS. In concert with these data, we did not observe E 2 -regulated binding of ERa to the proximal promoter sequences of mouse Pgr. We did, however identify two putative enhancer sites approximately 81 and 200 kb upstream of the mouse Pgr gene TSS, which displayed E 2 -regulated recruitment of ERa (Fig. 6 ). These were two out of seven ERE-containing sites homologous to the enhancer regions described by Boney-Montoya et al. (35) in human MCF-7 cells. Lack of E 2 -regulated binding at other five ERE-containing sites may be the result of sequence differences between species known to affect ERa binding (74) . Alternatively, other transcription factors may be required for the binding of ERa to the chromatin. Indeed, genomewide analysis of ERa binding sites revealed that one such factor, Forkhead (FoxA1), binds in the close proximity of ERa and is required for ERa association with chromatin in human cell line (34, 75) . Moreover, Fox1A has been identified as one of only four coregulators essential for the expression of the Pgr gene in MCF-7 cells (28) . Thus, further analyses of the role of this pioneer factor in the transcriptional activity of ERa in the mouse brain are warranted. Such studies will provide valuable information about the molecular mechanisms of E 2 -regulated gene expression in the brain and lead to a better understanding of the effects of hormones on CNS functions.
Conclusions
Although oestrogens exert a considerable influence on the variety of functions of the nervous system not only in females, but also in males, the studies of such influences have mostly focused on behavioural, physiological or pathological effect. Studies on molecular mechanisms that underlie the actions of oestrogens and the analyses of gene networks regulated by hormones are most often performed using more easily accessible and manipulated cell culture systems. This is understandable, considering the challenging technical issues that neuroscientists have to overcome when studying molecular events induced by ligand-activated hormone receptor in the brains of living animals: individual variability, as well as a small amount and heterogeneity of starting material (presence of glial cells, neurones that do not express ERa, and not all ERa expressing neurones being identical). As a result, molecular and biochemical changes in response to hormonal treatments are always more subtle in the brain than in the homologous cell culture systems. However, given the vastly diverse physiological, cellular and transcriptional effects that oestrogens exert on different tissues and cell types, it is of utmost importance to address the questions of molecular transcriptional mechanisms underlying oestrogens actions in a relevant system. Moreover, the prevalent use of hormone replacement therapy in postmenopausal women, as well as the use of different selective oestrogen receptor modulators for the treatment of breast and endometrial cancers or osteoporosis, highlights the immediate benefits of such studies aiming to understand the effects of hormones on women's health and disease
